CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: SMART PILLS TECHNOLOGY MARKET, BY APPLICATION
4.1 Overview
4.1.1 Market size and forecast
4.2 Capsule Endoscopy
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Drug Delivery
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Patient Monitoring
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
CHAPTER 5: SMART PILLS TECHNOLOGY MARKET, BY TARGET AREA
5.1 Overview
5.1.1 Market size and forecast
5.2 Esophagus
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Stomach
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Small Intestine
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Large Intestine
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
CHAPTER 6: SMART PILLS TECHNOLOGY MARKET, BY DISEASE INDICATION
6.1 Overview
6.1.1 Market size and forecast
6.2 Barrett’S Esophagus
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Small Bowel Diseases
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Colon Cancer
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
6.5 Others
6.5.1 Key market trends, growth factors and opportunities
6.5.2 Market size and forecast, by region
6.5.3 Market analysis by country
CHAPTER 7: SMART PILLS TECHNOLOGY MARKET, BY END USER
7.1 Overview
7.1.1 Market size and forecast
7.2 Hospitals and Clinics
7.2.1 Key market trends, growth factors and opportunities
7.2.2 Market size and forecast, by region
7.2.3 Market analysis by country
7.3 Diagnostic Centres
7.3.1 Key market trends, growth factors and opportunities
7.3.2 Market size and forecast, by region
7.3.3 Market analysis by country
7.4 Research Centres
7.4.1 Key market trends, growth factors and opportunities
7.4.2 Market size and forecast, by region
7.4.3 Market analysis by country
CHAPTER 8: SMART PILLS TECHNOLOGY MARKET, BY REGION
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key trends and opportunities
8.2.2 North America Market size and forecast, by Application
8.2.3 North America Market size and forecast, by Target Area
8.2.4 North America Market size and forecast, by Disease Indication
8.2.5 North America Market size and forecast, by End User
8.2.6 North America Market size and forecast, by country
8.2.6.1 U.S.
8.2.6.1.1 Market size and forecast, by Application
8.2.6.1.2 Market size and forecast, by Target Area
8.2.6.1.3 Market size and forecast, by Disease Indication
8.2.6.1.4 Market size and forecast, by End User
8.2.6.2 Canada
8.2.6.2.1 Market size and forecast, by Application
8.2.6.2.2 Market size and forecast, by Target Area
8.2.6.2.3 Market size and forecast, by Disease Indication
8.2.6.2.4 Market size and forecast, by End User
8.2.6.3 Mexico
8.2.6.3.1 Market size and forecast, by Application
8.2.6.3.2 Market size and forecast, by Target Area
8.2.6.3.3 Market size and forecast, by Disease Indication
8.2.6.3.4 Market size and forecast, by End User
8.3 Europe
8.3.1 Key trends and opportunities
8.3.2 Europe Market size and forecast, by Application
8.3.3 Europe Market size and forecast, by Target Area
8.3.4 Europe Market size and forecast, by Disease Indication
8.3.5 Europe Market size and forecast, by End User
8.3.6 Europe Market size and forecast, by country
8.3.6.1 Germany
8.3.6.1.1 Market size and forecast, by Application
8.3.6.1.2 Market size and forecast, by Target Area
8.3.6.1.3 Market size and forecast, by Disease Indication
8.3.6.1.4 Market size and forecast, by End User
8.3.6.2 France
8.3.6.2.1 Market size and forecast, by Application
8.3.6.2.2 Market size and forecast, by Target Area
8.3.6.2.3 Market size and forecast, by Disease Indication
8.3.6.2.4 Market size and forecast, by End User
8.3.6.3 U.K.
8.3.6.3.1 Market size and forecast, by Application
8.3.6.3.2 Market size and forecast, by Target Area
8.3.6.3.3 Market size and forecast, by Disease Indication
8.3.6.3.4 Market size and forecast, by End User
8.3.6.4 Italy
8.3.6.4.1 Market size and forecast, by Application
8.3.6.4.2 Market size and forecast, by Target Area
8.3.6.4.3 Market size and forecast, by Disease Indication
8.3.6.4.4 Market size and forecast, by End User
8.3.6.5 Spain
8.3.6.5.1 Market size and forecast, by Application
8.3.6.5.2 Market size and forecast, by Target Area
8.3.6.5.3 Market size and forecast, by Disease Indication
8.3.6.5.4 Market size and forecast, by End User
8.3.6.6 Rest of Europe
8.3.6.6.1 Market size and forecast, by Application
8.3.6.6.2 Market size and forecast, by Target Area
8.3.6.6.3 Market size and forecast, by Disease Indication
8.3.6.6.4 Market size and forecast, by End User
8.4 Asia-Pacific
8.4.1 Key trends and opportunities
8.4.2 Asia-Pacific Market size and forecast, by Application
8.4.3 Asia-Pacific Market size and forecast, by Target Area
8.4.4 Asia-Pacific Market size and forecast, by Disease Indication
8.4.5 Asia-Pacific Market size and forecast, by End User
8.4.6 Asia-Pacific Market size and forecast, by country
8.4.6.1 Japan
8.4.6.1.1 Market size and forecast, by Application
8.4.6.1.2 Market size and forecast, by Target Area
8.4.6.1.3 Market size and forecast, by Disease Indication
8.4.6.1.4 Market size and forecast, by End User
8.4.6.2 China
8.4.6.2.1 Market size and forecast, by Application
8.4.6.2.2 Market size and forecast, by Target Area
8.4.6.2.3 Market size and forecast, by Disease Indication
8.4.6.2.4 Market size and forecast, by End User
8.4.6.3 Australia
8.4.6.3.1 Market size and forecast, by Application
8.4.6.3.2 Market size and forecast, by Target Area
8.4.6.3.3 Market size and forecast, by Disease Indication
8.4.6.3.4 Market size and forecast, by End User
8.4.6.4 India
8.4.6.4.1 Market size and forecast, by Application
8.4.6.4.2 Market size and forecast, by Target Area
8.4.6.4.3 Market size and forecast, by Disease Indication
8.4.6.4.4 Market size and forecast, by End User
8.4.6.5 South Korea
8.4.6.5.1 Market size and forecast, by Application
8.4.6.5.2 Market size and forecast, by Target Area
8.4.6.5.3 Market size and forecast, by Disease Indication
8.4.6.5.4 Market size and forecast, by End User
8.4.6.6 Rest Of Asia Pacific
8.4.6.6.1 Market size and forecast, by Application
8.4.6.6.2 Market size and forecast, by Target Area
8.4.6.6.3 Market size and forecast, by Disease Indication
8.4.6.6.4 Market size and forecast, by End User
8.5 LAMEA
8.5.1 Key trends and opportunities
8.5.2 LAMEA Market size and forecast, by Application
8.5.3 LAMEA Market size and forecast, by Target Area
8.5.4 LAMEA Market size and forecast, by Disease Indication
8.5.5 LAMEA Market size and forecast, by End User
8.5.6 LAMEA Market size and forecast, by country
8.5.6.1 Brazil
8.5.6.1.1 Market size and forecast, by Application
8.5.6.1.2 Market size and forecast, by Target Area
8.5.6.1.3 Market size and forecast, by Disease Indication
8.5.6.1.4 Market size and forecast, by End User
8.5.6.2 South Africa,
8.5.6.2.1 Market size and forecast, by Application
8.5.6.2.2 Market size and forecast, by Target Area
8.5.6.2.3 Market size and forecast, by Disease Indication
8.5.6.2.4 Market size and forecast, by End User
8.5.6.3 Saudi Arabia
8.5.6.3.1 Market size and forecast, by Application
8.5.6.3.2 Market size and forecast, by Target Area
8.5.6.3.3 Market size and forecast, by Disease Indication
8.5.6.3.4 Market size and forecast, by End User
8.5.6.4 Rest of LAMEA
8.5.6.4.1 Market size and forecast, by Application
8.5.6.4.2 Market size and forecast, by Target Area
8.5.6.4.3 Market size and forecast, by Disease Indication
8.5.6.4.4 Market size and forecast, by End User
CHAPTER 9: COMPANY LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments
CHAPTER 10: COMPANY PROFILES
10.1 RF Co., Ltd
10.1.1 Company overview
10.1.2 Company snapshot
10.1.3 Operating business segments
10.1.4 Product portfolio
10.1.5 Business performance
10.1.6 Key strategic moves and developments
10.2 JINSHAN Science and Technology
10.2.1 Company overview
10.2.2 Company snapshot
10.2.3 Operating business segments
10.2.4 Product portfolio
10.2.5 Business performance
10.2.6 Key strategic moves and developments
10.3 Proteus Digital Health
10.3.1 Company overview
10.3.2 Company snapshot
10.3.3 Operating business segments
10.3.4 Product portfolio
10.3.5 Business performance
10.3.6 Key strategic moves and developments
10.4 HQ, Inc.
10.4.1 Company overview
10.4.2 Company snapshot
10.4.3 Operating business segments
10.4.4 Product portfolio
10.4.5 Business performance
10.4.6 Key strategic moves and developments
10.5 CapsoVision, Inc.
10.5.1 Company overview
10.5.2 Company snapshot
10.5.3 Operating business segments
10.5.4 Product portfolio
10.5.5 Business performance
10.5.6 Key strategic moves and developments
10.6 Medtronic Plc.
10.6.1 Company overview
10.6.2 Company snapshot
10.6.3 Operating business segments
10.6.4 Product portfolio
10.6.5 Business performance
10.6.6 Key strategic moves and developments
10.7 Olympus Corporations
10.7.1 Company overview
10.7.2 Company snapshot
10.7.3 Operating business segments
10.7.4 Product portfolio
10.7.5 Business performance
10.7.6 Key strategic moves and developments
10.8 IntroMedic Co., Ltd
10.8.1 Company overview
10.8.2 Company snapshot
10.8.3 Operating business segments
10.8.4 Product portfolio
10.8.5 Business performance
10.8.6 Key strategic moves and developments
10.9 Check Cap
10.9.1 Company overview
10.9.2 Company snapshot
10.9.3 Operating business segments
10.9.4 Product portfolio
10.9.5 Business performance
10.9.6 Key strategic moves and developments
10.10 Koninklijke Philips N.V
10.10.1 Company overview
10.10.2 Company snapshot
10.10.3 Operating business segments
10.10.4 Product portfolio
10.10.5 Business performance
10.10.6 Key strategic moves and developments
TABLE 1. GLOBAL SMART PILLS TECHNOLOGY MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 2. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR CAPSULE ENDOSCOPY, BY REGION , 2020-2030,($MILLION)
TABLE 3. SMART PILLS TECHNOLOGY MARKET CAPSULE ENDOSCOPY BY COUNTRY, 2020-2030,($MILLION)
TABLE 4. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR DRUG DELIVERY, BY REGION , 2020-2030,($MILLION)
TABLE 5. SMART PILLS TECHNOLOGY MARKET DRUG DELIVERY BY COUNTRY, 2020-2030,($MILLION)
TABLE 6. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR PATIENT MONITORING, BY REGION , 2020-2030,($MILLION)
TABLE 7. SMART PILLS TECHNOLOGY MARKET PATIENT MONITORING BY COUNTRY, 2020-2030,($MILLION)
TABLE 8. GLOBAL SMART PILLS TECHNOLOGY MARKET, BY TARGET AREA, 2020-2030,($MILLION)
TABLE 9. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR ESOPHAGUS, BY REGION , 2020-2030,($MILLION)
TABLE 10. SMART PILLS TECHNOLOGY MARKET ESOPHAGUS BY COUNTRY, 2020-2030,($MILLION)
TABLE 11. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR STOMACH, BY REGION , 2020-2030,($MILLION)
TABLE 12. SMART PILLS TECHNOLOGY MARKET STOMACH BY COUNTRY, 2020-2030,($MILLION)
TABLE 13. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR SMALL INTESTINE, BY REGION , 2020-2030,($MILLION)
TABLE 14. SMART PILLS TECHNOLOGY MARKET SMALL INTESTINE BY COUNTRY, 2020-2030,($MILLION)
TABLE 15. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR LARGE INTESTINE, BY REGION , 2020-2030,($MILLION)
TABLE 16. SMART PILLS TECHNOLOGY MARKET LARGE INTESTINE BY COUNTRY, 2020-2030,($MILLION)
TABLE 17. GLOBAL SMART PILLS TECHNOLOGY MARKET, BY DISEASE INDICATION, 2020-2030,($MILLION)
TABLE 18. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR BARRETT'S ESOPHAGUS, BY REGION , 2020-2030,($MILLION)
TABLE 19. SMART PILLS TECHNOLOGY MARKET BARRETT'S ESOPHAGUS BY COUNTRY, 2020-2030,($MILLION)
TABLE 20. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR SMALL BOWEL DISEASES, BY REGION , 2020-2030,($MILLION)
TABLE 21. SMART PILLS TECHNOLOGY MARKET SMALL BOWEL DISEASES BY COUNTRY, 2020-2030,($MILLION)
TABLE 22. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR COLON CANCER, BY REGION , 2020-2030,($MILLION)
TABLE 23. SMART PILLS TECHNOLOGY MARKET COLON CANCER BY COUNTRY, 2020-2030,($MILLION)
TABLE 24. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR OTHERS, BY REGION , 2020-2030,($MILLION)
TABLE 25. SMART PILLS TECHNOLOGY MARKET OTHERS BY COUNTRY, 2020-2030,($MILLION)
TABLE 26. GLOBAL SMART PILLS TECHNOLOGY MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 27. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR HOSPITALS AND CLINICS, BY REGION , 2020-2030,($MILLION)
TABLE 28. SMART PILLS TECHNOLOGY MARKET HOSPITALS AND CLINICS BY COUNTRY, 2020-2030,($MILLION)
TABLE 29. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR DIAGNOSTIC CENTRES, BY REGION , 2020-2030,($MILLION)
TABLE 30. SMART PILLS TECHNOLOGY MARKET DIAGNOSTIC CENTRES BY COUNTRY, 2020-2030,($MILLION)
TABLE 31. SMART PILLS TECHNOLOGY MARKET REVENUE, FOR RESEARCH CENTRES, BY REGION , 2020-2030,($MILLION)
TABLE 32. SMART PILLS TECHNOLOGY MARKET RESEARCH CENTRES BY COUNTRY, 2020-2030,($MILLION)
TABLE 33. SMART PILLS TECHNOLOGY MARKET, BY REGION, 2020-2030,($MILLION)
TABLE 34. NORTH AMERICA SMART PILLS TECHNOLOGY MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 35. NORTH AMERICA SMART PILLS TECHNOLOGY MARKET, BY TARGET AREA, 2020-2030,($MILLION)
TABLE 36. NORTH AMERICA SMART PILLS TECHNOLOGY MARKET, BY DISEASE INDICATION, 2020-2030,($MILLION)
TABLE 37. NORTH AMERICA SMART PILLS TECHNOLOGY MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 38. NORTH AMERICA SMART PILLS TECHNOLOGY MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 39. U.S. SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 40. U.S. SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
TABLE 41. U.S. SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
TABLE 42. U.S. SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
TABLE 43. CANADA SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 44. CANADA SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
TABLE 45. CANADA SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
TABLE 46. CANADA SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
TABLE 47. MEXICO SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 48. MEXICO SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
TABLE 49. MEXICO SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
TABLE 50. MEXICO SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
TABLE 51. EUROPE SMART PILLS TECHNOLOGY MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 52. EUROPE SMART PILLS TECHNOLOGY MARKET, BY TARGET AREA, 2020-2030,($MILLION)
TABLE 53. EUROPE SMART PILLS TECHNOLOGY MARKET, BY DISEASE INDICATION, 2020-2030,($MILLION)
TABLE 54. EUROPE SMART PILLS TECHNOLOGY MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 55. EUROPE SMART PILLS TECHNOLOGY MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 56. GERMANY SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 57. GERMANY SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
TABLE 58. GERMANY SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
TABLE 59. GERMANY SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
TABLE 60. FRANCE SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 61. FRANCE SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
TABLE 62. FRANCE SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
TABLE 63. FRANCE SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
TABLE 64. U.K. SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 65. U.K. SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
TABLE 66. U.K. SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
TABLE 67. U.K. SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
TABLE 68. ITALY SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 69. ITALY SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
TABLE 70. ITALY SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
TABLE 71. ITALY SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
TABLE 72. SPAIN SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 73. SPAIN SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
TABLE 74. SPAIN SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
TABLE 75. SPAIN SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
TABLE 76. REST OF EUROPE SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 77. REST OF EUROPE SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
TABLE 78. REST OF EUROPE SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
TABLE 79. REST OF EUROPE SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
TABLE 80. ASIA-PACIFIC SMART PILLS TECHNOLOGY MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 81. ASIA-PACIFIC SMART PILLS TECHNOLOGY MARKET, BY TARGET AREA, 2020-2030,($MILLION)
TABLE 82. ASIA-PACIFIC SMART PILLS TECHNOLOGY MARKET, BY DISEASE INDICATION, 2020-2030,($MILLION)
TABLE 83. ASIA-PACIFIC SMART PILLS TECHNOLOGY MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 84. ASIA-PACIFIC SMART PILLS TECHNOLOGY MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 85. JAPAN SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 86. JAPAN SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
TABLE 87. JAPAN SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
TABLE 88. JAPAN SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
TABLE 89. CHINA SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 90. CHINA SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
TABLE 91. CHINA SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
TABLE 92. CHINA SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
TABLE 93. AUSTRALIA SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 94. AUSTRALIA SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
TABLE 95. AUSTRALIA SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
TABLE 96. AUSTRALIA SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
TABLE 97. INDIA SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 98. INDIA SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
TABLE 99. INDIA SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
TABLE 100. INDIA SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
TABLE 101. SOUTH KOREA SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 102. SOUTH KOREA SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
TABLE 103. SOUTH KOREA SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
TABLE 104. SOUTH KOREA SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
TABLE 105. REST OF ASIA PACIFIC SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 106. REST OF ASIA PACIFIC SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
TABLE 107. REST OF ASIA PACIFIC SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
TABLE 108. REST OF ASIA PACIFIC SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
TABLE 109. LAMEA SMART PILLS TECHNOLOGY MARKET, BY APPLICATION, 2020-2030,($MILLION)
TABLE 110. LAMEA SMART PILLS TECHNOLOGY MARKET, BY TARGET AREA, 2020-2030,($MILLION)
TABLE 111. LAMEA SMART PILLS TECHNOLOGY MARKET, BY DISEASE INDICATION, 2020-2030,($MILLION)
TABLE 112. LAMEA SMART PILLS TECHNOLOGY MARKET, BY END USER, 2020-2030,($MILLION)
TABLE 113. LAMEA SMART PILLS TECHNOLOGY MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 114. BRAZIL SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 115. BRAZIL SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
TABLE 116. BRAZIL SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
TABLE 117. BRAZIL SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
TABLE 118. SOUTH AFRICA, SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 119. SOUTH AFRICA, SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
TABLE 120. SOUTH AFRICA, SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
TABLE 121. SOUTH AFRICA, SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
TABLE 122. SAUDI ARABIA SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 123. SAUDI ARABIA SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
TABLE 124. SAUDI ARABIA SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
TABLE 125. SAUDI ARABIA SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
TABLE 126. REST OF LAMEA SMART PILLS TECHNOLOGY MARKET BY APPLICATION 2020-2030,($MILLION)
TABLE 127. REST OF LAMEA SMART PILLS TECHNOLOGY MARKET BY TARGET AREA 2020-2030,($MILLION)
TABLE 128. REST OF LAMEA SMART PILLS TECHNOLOGY MARKET BY DISEASE INDICATION 2020-2030,($MILLION)
TABLE 129. REST OF LAMEA SMART PILLS TECHNOLOGY MARKET BY END USER 2020-2030,($MILLION)
TABLE 130.RF CO., LTD: COMPANY SNAPSHOT
TABLE 131.RF CO., LTD: OPERATING SEGMENTS
TABLE 132.RF CO., LTD: PRODUCT PORTFOLIO
TABLE 133.RF CO., LTD: NET SALES,
TABLE 134.RF CO., LTD: KEY STRATERGIES
TABLE 135.JINSHAN SCIENCE AND TECHNOLOGY: COMPANY SNAPSHOT
TABLE 136.JINSHAN SCIENCE AND TECHNOLOGY: OPERATING SEGMENTS
TABLE 137.JINSHAN SCIENCE AND TECHNOLOGY: PRODUCT PORTFOLIO
TABLE 138.JINSHAN SCIENCE AND TECHNOLOGY: NET SALES,
TABLE 139.JINSHAN SCIENCE AND TECHNOLOGY: KEY STRATERGIES
TABLE 140.PROTEUS DIGITAL HEALTH: COMPANY SNAPSHOT
TABLE 141.PROTEUS DIGITAL HEALTH: OPERATING SEGMENTS
TABLE 142.PROTEUS DIGITAL HEALTH: PRODUCT PORTFOLIO
TABLE 143.PROTEUS DIGITAL HEALTH: NET SALES,
TABLE 144.PROTEUS DIGITAL HEALTH: KEY STRATERGIES
TABLE 145.HQ, INC.: COMPANY SNAPSHOT
TABLE 146.HQ, INC.: OPERATING SEGMENTS
TABLE 147.HQ, INC.: PRODUCT PORTFOLIO
TABLE 148.HQ, INC.: NET SALES,
TABLE 149.HQ, INC.: KEY STRATERGIES
TABLE 150.CAPSOVISION, INC.: COMPANY SNAPSHOT
TABLE 151.CAPSOVISION, INC.: OPERATING SEGMENTS
TABLE 152.CAPSOVISION, INC.: PRODUCT PORTFOLIO
TABLE 153.CAPSOVISION, INC.: NET SALES,
TABLE 154.CAPSOVISION, INC.: KEY STRATERGIES
TABLE 155.MEDTRONIC PLC.: COMPANY SNAPSHOT
TABLE 156.MEDTRONIC PLC.: OPERATING SEGMENTS
TABLE 157.MEDTRONIC PLC.: PRODUCT PORTFOLIO
TABLE 158.MEDTRONIC PLC.: NET SALES,
TABLE 159.MEDTRONIC PLC.: KEY STRATERGIES
TABLE 160.OLYMPUS CORPORATIONS: COMPANY SNAPSHOT
TABLE 161.OLYMPUS CORPORATIONS: OPERATING SEGMENTS
TABLE 162.OLYMPUS CORPORATIONS: PRODUCT PORTFOLIO
TABLE 163.OLYMPUS CORPORATIONS: NET SALES,
TABLE 164.OLYMPUS CORPORATIONS: KEY STRATERGIES
TABLE 165.INTROMEDIC CO., LTD: COMPANY SNAPSHOT
TABLE 166.INTROMEDIC CO., LTD: OPERATING SEGMENTS
TABLE 167.INTROMEDIC CO., LTD: PRODUCT PORTFOLIO
TABLE 168.INTROMEDIC CO., LTD: NET SALES,
TABLE 169.INTROMEDIC CO., LTD: KEY STRATERGIES
TABLE 170.CHECK CAP: COMPANY SNAPSHOT
TABLE 171.CHECK CAP: OPERATING SEGMENTS
TABLE 172.CHECK CAP: PRODUCT PORTFOLIO
TABLE 173.CHECK CAP: NET SALES,
TABLE 174.CHECK CAP: KEY STRATERGIES
TABLE 175.KONINKLIJKE PHILIPS N.V: COMPANY SNAPSHOT
TABLE 176.KONINKLIJKE PHILIPS N.V: OPERATING SEGMENTS
TABLE 177.KONINKLIJKE PHILIPS N.V: PRODUCT PORTFOLIO
TABLE 178.KONINKLIJKE PHILIPS N.V: NET SALES,
TABLE 179.KONINKLIJKE PHILIPS N.V: KEY STRATERGIES
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/